{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:46:08Z","timestamp":1793666768969,"version":"4.5.1"},"reference-count":89,"publisher":"The Korean Society of Applied Pharmacology","issue":"4","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.biomolther.org"],"crossmark-restriction":true},"short-container-title":["Biomol Ther (Seoul)"],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.4062\/biomolther.2025.022","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:34:23Z","timestamp":1750307663000},"page":"572-581","update-policy":"https:\/\/doi.org\/10.4062\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System"],"prefix":"10.4062","volume":"33","author":[{"given":"Bet\u00fcl","family":"Ertural","sequence":"first","affiliation":[{"name":"Gebze Technical University, Department of Molecular Biology and Genetics, 41400 Gebze Kocaeli, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra Nur","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[{"name":"Gebze Technical University, Department of Molecular Biology and Genetics, 41400 Gebze Kocaeli, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015f\u0131l Aksan","family":"Kurnaz","sequence":"additional","affiliation":[{"name":"Gebze Technical University, Department of Molecular Biology and Genetics, 41400 Gebze Kocaeli, Turkiye"},{"name":"Gebze Technical University, Institute of Biotechnology, 41400 Gebze Kocaeli, Turkiye"},{"name":"Bogazici University, Center for Life Sciences and Technologies (LifeSci), Kandilli Campus, 34684 Uskudar Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2506","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2017.0665"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.07.027"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.joc.0c02291"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.996545"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2245"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-022-01007-9"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-070918-050501"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.05.017"},{"key":"ref9","unstructured":"Biogen. (2022) Biogen and ionis announce topline phase 1 study results of investigational drug in C9orf72 amyotrophic lateral sclerosis. Available from: <a target=\"_blank\" href=\"https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-and-ionis-announce-topline-phase-1-study-results\/\">https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-and-ionis-announce-topline-phase-1-study-results\/<\/a>."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01904-6"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002154"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab423"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2020.08.012"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00644-7"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14304\/SURYA.JPR.V4N7.5"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.01.013"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002445"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18688"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1304342"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04469.x"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.628137"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9062004"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.774366"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/med.21706"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.11.074"},{"key":"ref26","unstructured":"European Medicines Agency. (2024) Guideline on the development and manufacture of oligonucleotides (EMA\/CHMP\/CVMP\/QWP\/262313\/2024). Available from: <a target=\"_blank\" href=\"https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-development-manufacture-oligonucleotides_en.pdf\/\">https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-development-manufacture-oligonucleotides_en.pdf\/<\/a>."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22187"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024308"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114444"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ph12020078"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040833"},{"key":"ref32","unstructured":"Gao, S. and Benyahia, B. (2023) In Proceedings of the 33rd European Symposium on Computer-Aided Process Engineering (ESCAPE33) (June 18-21, 2023). Athens, Greece."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4155\/bio.10.76"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21022-9"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.01.008"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008204"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1811850"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103691"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01974-7"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1360302"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010110"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01267-2"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1159\/000517686"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2022.2066334"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0802-1"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.33393\/grhta.2021.2193"},{"key":"ref47","unstructured":"Ionis Pharmaceuticals. (2023) WAINUA\u2122 (eplontersen) granted regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis. Available from: <a target=\"_blank\" href=\"https:\/\/ir.ionis.com\/news-releases\/news-release-details\/wainuatm-eplontersen-granted-regulatory-approval-us-treatment\/\">https:\/\/ir.ionis.com\/news-releases\/news-release-details\/wainuatm-eplontersen-granted-regulatory-approval-us-treatment\/<\/a>."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01948-8"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0968-5"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00419-1"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25676"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/kidneydial2010004"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1021\/cbmi.4c00012"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S97635"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2021.10.018"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102340"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28372"},{"key":"ref58","unstructured":"Lowe, D. (2009) The great acetonitrile shortage. Science Blog. Available from: <a target=\"_blank\" href=\"https:\/\/www.science.org\/content\/blog-post\/great-acetonitrile-shortage\/\">https:\/\/www.science.org\/content\/blog-post\/great-acetonitrile-shortage\/<\/a>."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0557-5"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020760"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2300400"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000417"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201914751"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010787"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00439-4"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-05290-0"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.148"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0075-7"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00519-9"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00665-2"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01766-3"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1239"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01512-2"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0657-1"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900907"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040359"},{"key":"ref77","unstructured":"U.S. Food and Drug Administration. (2021) IND submissions for individualized antisense oligonucleotide drug products for severely debilitating or life-threatening diseases: Clinical recommendations (Draft Guidance) Center for Drug Evaluation and Research. Available from: <a target=\"_blank\" href=\"https:\/\/www.fda.gov\/media\/154663\/download\/\">https:\/\/www.fda.gov\/media\/154663\/download\/<\/a>."},{"key":"ref78","unstructured":"U.S. Food and Drug Administration. (2024) Clinical pharmacology considerations for the development of oligonucleotide therapeutics (Guidance for Industry) Center for Drug Evaluation and Research. Available from: <a target=\"_blank\" href=\"https:\/\/www.fda.gov\/media\/159414\/download\/\">https:\/\/www.fda.gov\/media\/159414\/download\/<\/a>."},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00216-3"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114236"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2023.02.022"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2023.08.005"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20230036"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073295"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-08224-0"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01582-2"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S288859"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-022-2171-2"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.08.002"}],"container-title":["Biomolecules &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pdf.medrang.co.kr\/BT2\/2025\/033\/BT033-04-02.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"https:\/\/pdf.medrang.co.kr\/BT2\/2025\/033\/BT033-04-02.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T04:50:53Z","timestamp":1752727853000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomolther.org\/journal\/view.html?doi=10.4062\/biomolther.2025.022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,1]]}},"alternative-id":["10.4062\/biomolther.2025.022"],"URL":"https:\/\/doi.org\/10.4062\/biomolther.2025.022","relation":{},"ISSN":["1976-9148","2005-4483"],"issn-type":[{"value":"1976-9148","type":"print"},{"value":"2005-4483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"http:\/\/www.biomolther.org\/journal\/view.html?doi=10.4062\/biomolther.2025.022","URL":"http:\/\/www.biomolther.org\/journal\/view.html?doi=10.4062\/biomolther.2025.022","name":"the_journal","label":"Biomolecules & Therapeutics","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2025-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-19","order":3,"name":"published","label":"Online First","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":4,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2025 The Korean Society of Applied Pharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}